C.s.t. Pharma Group Holdings Limited in Walsall, WS9 8ER

Description

Data updated on: 01-11-2023

Located in Unit 5-7 Tintagel Way, Walsall WS9 8ER C.s.t. Pharma Group Holdings Limited is classified as a Private Limited Company registered under the 11435398 registration number. It has been established six years ago. The official name switch from St Topco (UK) to C.s.t. Pharma Group Holdings Limited occurred on 2019-11-06. This firm's declared SIC number is 64209 meaning Activities of other holding companies n.e.c.. C.s.t. Pharma Group Holdings Ltd released its latest accounts for the financial period up to 30th April 2022. The business most recent annual confirmation statement was submitted on 26th June 2023.

Our database regarding this particular firm's members implies that there are four directors: Ian P., Caroline P., Carl F. and Jason Y. who were appointed to their positions on 2019-08-05, 2018-08-28 and 2018-08-02.

Jason Y. is the individual who has control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Previous company's names
C.s.t. Pharma Group Holdings Limited 2019-11-06
St Topco (UK) Limited 2018-06-27

Financial data based on annual reports

Profit & Loss
Date of Accounts	2022-04-30	2023-04-30
Currency

Balance Sheet
Cash Bank On Hand	187 048
Current Assets	951 750	50 333
Debtors	764 702	50 333

Other Financial Data
Accrued Liabilities Deferred Income	177 814	329 271
Accumulated Amortisation Impairment Intangible Assets	328 553	509 980
Accumulated Depreciation Impairment Property Plant Equipment	779 432	876 753
Additions Other Than Through Business Combinations Intangible Assets		186 429
Additions Other Than Through Business Combinations Property Plant Equipment		23 276
Administrative Expenses	7 501 506	8 028 974
Amounts Owed To Group Undertakings		282 721
Average Number Employees During Period	4	4
Bank Borrowings	181 245	172 392
Bank Borrowings Overdrafts	181 245	172 392
Cash Cash Equivalents	730 362	227 266
Comprehensive Income Expense		3 041 463
Corporation Tax Payable	471 305	164 817
Cost Sales	97 099 300	106 817 852
Creditors	2 425 114	1 062 103
Current Tax For Period	621 340	524 817
Deferred Tax Expense Credit From Unrecognised Timing Difference From Prior Period	36 482	-44 888
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences		-44 888
Dividends Paid Classified As Financing Activities	-223 332	-229 095
Dividends Paid To Owners Parent Classified As Financing Activities	-224 332	-229 095
Finance Lease Liabilities Present Value Total	125 402	116 756
Finance Lease Payments Owing Minimum Gross	120 368	72 374
Finished Goods Goods For Resale		13 517 107
Further Item Tax Increase Decrease Component Adjusting Items		-12 202
Income Taxes Paid Refund Classified As Operating Activities	-561 395
Increase Decrease In Current Tax From Adjustment For Prior Periods	-16 822	-14 984
Increase From Amortisation Charge For Year Intangible Assets		181 427
Increase From Depreciation Charge For Year Property Plant Equipment		97 321
Intangible Assets	485 093	490 095
Intangible Assets Gross Cost	813 646	1 000 075
Interest Expense On Convertible Borrowings	492 746	747 854
Interest Paid Classified As Operating Activities		-809 044
Interest Payable Similar Charges Finance Costs	548 378	809 044
Investments	4 148 469	4 148 469
Investments Fixed Assets	4 148 469	4 148 469
Investments In Associates	898 569	897 765
Other Creditors	2 247 300	13 618 685
Pension Other Post-employment Benefit Costs Other Pension Costs	201 369	128 141
Percentage Class Share Held In Associate		25
Percentage Class Share Held In Subsidiary		100
Prepayments Accrued Income	242 019	774 511
Profit Loss	1 134 916	690 689
Property Plant Equipment Gross Cost	1 150 471	1 173 747
Staff Costs Employee Benefits Expense	4 777 649	4 585 590
Taxation Including Deferred Taxation Balance Sheet Subtotal	44 888
Tax Decrease From Utilisation Tax Losses		29 191
Tax Increase Decrease From Effect Adjustment In Research Development Tax Credit	-13 031
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss	-36 482	-7 367
Tax Tax Credit On Profit Or Loss On Ordinary Activities	604 518	464 945
Total Borrowings	181 245	172 392
Total Current Tax Expense Credit	604 518	509 833
Trade Creditors Trade Payables	3 866 197	3 484 737
Trade Debtors Trade Receivables	10 473 474	12 397 660
Wages Salaries		4 457 449

Company staff

Ian P.

Role: Director

Appointed: 05 August 2019

Latest update: 15 April 2024

Caroline P.

Role: Director

Appointed: 28 August 2018

Latest update: 15 April 2024

Carl F.

Role: Director

Appointed: 28 August 2018

Latest update: 15 April 2024

Jason Y.

Role: Director

Appointed: 02 August 2018

Latest update: 15 April 2024

People with significant control

Jason Y.

Notified on 27 June 2018

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 January 2024
Account last made up date	30 April 2022
Confirmation statement next due date	10 July 2024
Confirmation statement last made up date	26 June 2023

Annual Accounts
Start Date For Period Covered By Report	2022-05-01
End Date For Period Covered By Report	2023-04-30

C.s.t. Pharma Group Holdings Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Ian P.

Caroline P.

Carl F.

Jason Y.

Michelle G.

Daniel O.

People with significant control

Jason Y.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies